Novel Stroke Risk Reduction Option for Indicated Patients with Atrial Fibrillation "With today's successful implantations of the WATCHMAN Device, we are changing the way we deal with stroke risk in ...

Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Atrial Fibrillation - Pipeline ...

Atrial fibrillation is a disorder where the two upper chambers of the heart (atria) beat ineffectively and out of sync from the lower chambers (ventricles). When this rhythm occurs the atria are not ...

This milestone marks the commercial launch of the company’s next-generation system The inaugural U.S. procedures were performed by Dr. Devi Nair, Chief of Cardiac Electrophysiology and EP Research at ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...